01 1Shanghai Ziyuan Pharmaceutical
01 1FOSPHENYTOIN SODIUM USP
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2017-06-16
Pay. Date : 2017-05-23
DMF Number : 17333
Submission : 2004-04-26
Status : Active
Type : II
20
Shanghai Ziyuan Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is FOSPHENYTOIN SODIUM USP, with a corresponding US DMF Number 17333.
Remarkably, this DMF maintains an Active status since its submission on April 26, 2004, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 16, 2017, and payment made on May 23, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II
